Evidence map›Paper›PMID 41159405›Full record

ArticleChembiochem : a European journal of chemical biology2025

Enhancing Antigen Recognition of Living Cells by Site-Specific VHH Antibody Conjugation.

Chengyuan Zhu, Yudai Ichikawa, Fumiyoshi Yamashita, Yuriko Higuchi

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Enhancing Antigen Recognition of Living Cells by Site-Specific VHH Antibody Conjugation.Chembiochem : a European journal of chemical biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Chengyuan ZhuDepartment of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan.
Yudai IchikawaDepartment of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan.
Fumiyoshi YamashitaDepartment of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan.
Yuriko HiguchiDepartment of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan.ORCID https://orcid.org/0000-0002-9869-1019

Funding

Japan Society for the Promotion of Science JP22K19917Japan Society for the Promotion of Science JP23K25194
6 · The paper itself

Abstract

Biosensors and microdevices using living cells have gained significant attention in recent years, including methods for cell immobilization on antibody-coated surfaces. Random antibody fixation may lead to suboptimal exposure of recognition sites, reducing interaction efficiency. In contrast, aligned antibody immobilization enhances antigen recognition and binding capacity during cell immobilization. Site incorporation of azido-phenylalanine (AzF) into antibodies facilitates site-specific conjugation, enabling aligned antibody immobilization. In this study, we expressed and purified anti-mCherry variable domains of heavy-chain-only antibodies (VHHs), incorporating AzF at the C-terminus using an unnatural amino acid system to ensure its placement away from the antigen-binding site for mCherry. Anti-mCherry VHH-AzF was conjugated to dibenzylcyclooctyne (DBCO)-coated glass via click chemistry, followed by incubation with HeLa cells expressing mCherry on their surfaces (mCherry-coated cells). This resulted in increased immobilization of mCherry-coated cells on the VHH-coated glass, whereas normal HeLa cells did not adhere.

Indexed as

Antibodies, ImmobilizedAntigensSingle-Domain AntibodiesAzidesClick ChemistryHeLa CellsHumansLuminescent ProteinsPhenylalanineRed Fluorescent Protein4-azidophenylalanineAntibodies, ImmobilizedAntigensAzidesLuminescent ProteinsPhenylalanineRed Fluorescent ProteinSingle-Domain Antibodiesantibody alignmentcell immobilizationclick chemistryunnatural amino acidVHH antibody

Identifiers

PMID41159405
PMCPMC12631000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.